DrugPatentWatch Database Preview

Casi Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?

CASI PHARMS INC has twenty-five approved drugs.

Summary for Casi Pharms Inc

US Patents:	0
Tradenames:	23
Ingredients:	23
NDAs:	25

Drugs and US Patents for Casi Pharms Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Casi Pharms Inc	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	076514-001	Sep 11, 2003	AB	RX	No	No
Casi Pharms Inc	SPIRONOLACTONE	spironolactone	TABLET;ORAL	086809-001	Approved Prior to Jan 1, 1982	AB	RX	No	No
Casi Pharms Inc	REPAGLINIDE	repaglinide	TABLET;ORAL	078555-003	Jan 22, 2014	AB	RX	No	No
Casi Pharms Inc	ENTECAVIR	entecavir	TABLET;ORAL	206672-001	May 11, 2017	AB	RX	No	No
Casi Pharms Inc	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	091659-001	Jun 8, 2011	AP	RX	No	No
Casi Pharms Inc	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	076514-002	Sep 11, 2003	AB	RX	No	No
Casi Pharms Inc	LISINOPRIL	lisinopril	TABLET;ORAL	075994-004	Jul 1, 2002	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Casi Pharms Inc